Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Q32 Bio (QTTB) Equity Income (2022 - 2024)

Q32 Bio (QTTB) has 2 years of Equity Income data on record, last reported at -$1.4 million in Q2 2024.

  • For Q2 2024, Equity Income changed N/A year-over-year to -$1.4 million; the TTM value through Sep 2025 reached -$1.4 million, up 10.83%, while the annual FY2024 figure was -$1.6 million, N/A changed from the prior year.
  • Equity Income reached -$1.4 million in Q2 2024 per QTTB's latest filing, down from -$176000.0 in the prior quarter.
  • Across five years, Equity Income topped out at -$176000.0 in Q1 2024 and bottomed at -$2.2 million in Q3 2022.